Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease

References

• Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, et al.; Global Health Epidemiology Reference Group (GHERG). 2015. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 5:020415.
   PubMed Web of Science ®Google Scholar
• Agbetile J, Fairs A, Desai D, Hargadon B, Bourne M, Mutalithas K, Edwards R, Morley JP, Monteiro WR, Kulkarni NS, et al. 2012. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy. 42:782–791.
   PubMed Web of Science ®Google Scholar
• Ahearn CP, Gallo MC, Murphy TF. 2017. Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Pathog Dis. 75:ftx042.
   PubMed Web of Science ®Google Scholar
• Allard JB, Rinaldi L, Wargo MJ, Allen G, Akira S, Uematsu S, Poynter ME, Hogan DA, Rincon M, Whittaker LA. 2009. Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products. Eur J Immunol. 39:776–788.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Mckenna S, Agbetile J, Fairs A, Desai D, Mistry V, Morley JP, Pancholi M, Pavord ID, Wardlaw AJ, et al. 2014. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 43:64–71.
   PubMed Web of Science ®Google Scholar
• Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, Beck JM, Curtis JL, Huffnagle GB. 2015. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio. 6:e00037.
   PubMed Web of Science ®Google Scholar
• Blakeway LV, Tan A, Peak IRA, Seib KL. 2017. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development. Microbiology (Reading). 163:1371–1384.
   PubMed Web of Science ®Google Scholar
• Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, Esser MT, Sellman BR, Jin H. 2020. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res. 21:77.
   PubMed Web of Science ®Google Scholar
• Brenner DR, McLaughlin JR, Hung RJ. 2011. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 6:e17479.
   PubMed Web of Science ®Google Scholar
• Briard B, Mislin GLA, Latgé JP, Beauvais A. 2019. Interactions between Aspergillus fumigatus and pulmonary bacteria: current state of the field, new data, and future perspective. J Fungi (Basel). 5:48.
   PubMedGoogle Scholar
• Cabrera-Rubio R, Garcia-Nunez M, Seto L, Anto JM, Moya A, Monso E, Mira A. 2012. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol. 50:3562–3568.
   PubMed Web of Science ®Google Scholar
• Cameron SJ, Lewis KE, Huws SA, Lin W, Hegarty MJ, Lewis PD, Mur LA, Pachebat JA. 2016. Metagenomic sequencing of the chronic obstructive pulmonary disease upper bronchial tract microbiome reveals functional changes associated with disease severity. PLoS One. 11:e0149095.
   PubMed Web of Science ®Google Scholar
• Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. 2011. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 184:957–963.
   PubMed Web of Science ®Google Scholar
• Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. 2010. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol. 45:1111–1120.
   PubMed Web of Science ®Google Scholar
• Choi KJ, Cha SI, Shin KM, Lee J, Hwangbo Y, Yoo SS, Lee J, Lee SY, Kim CH, Park JY, et al. 2013. Prevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary disease. Respiration. 85:203–209.
   PubMed Web of Science ®Google Scholar
• Churg A, Zhou S, Wright JL. 2012. Series “matrix metalloproteinases in lung health and disease”: matrix metalloproteinases in COPD. Eur Respir J. 39:197–209.
   PubMed Web of Science ®Google Scholar
• Clancy RL, Dunkley ML, Sockler J, McDonald CF. 2016. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Intern Med J. 46:684–693.
   PubMed Web of Science ®Google Scholar
• Cui L, Lucht L, Tipton L, Rogers MB, Fitch A, Kessinger C, Camp D, Kingsley L, Leo N, Greenblatt RM, et al. 2015. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am J Respir Crit Care Med. 191:932–942.
   PubMed Web of Science ®Google Scholar
• de Marcken M, Dhaliwal K, Danielsen AC, Gautron AS. 2019. Dominguez-Villar M: TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection. Sci Signal. 12:31662487.
   Web of Science ®Google Scholar
• Dickson RP, Schultz MJ, der Poll TV, Schouten LR, Falkowski NR, Luth JE, Sjoding MW, Brown CA, Chanderraj R, Huffnagle GB, et al.; Biomarker Analysis in Septic ICU Patients (BASIC) Consortium. 2020. Lung microbiota predict clinical outcomes in critically ill Patients. Am J Respir Crit Care Med. 201:555–563.
   PubMedGoogle Scholar
• Edwards MR, Strong K, Cameron A, Walton RP, Jackson DJ, Johnston SL. 2017. Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness. J Allergy Clin Immunol. 140:909–920.
   PubMed Web of Science ®Google Scholar
• Einarsson GG, Comer DM, Mcilreavey L, Parkhill J, Ennis M, Tunney MM, Elborn JS. 2016. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 71:795–803.
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, et al. 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 6:e16384.
   PubMed Web of Science ®Google Scholar
• Fan VS, Gharib SA, Martin TR. 2016. Wurfel MM: COPD disease severity and innate immune response to pathogen-associated molecular patterns. Int J Chron Obstruct Pulmon Dis. 11:467–477.
   PubMed Web of Science ®Google Scholar
• Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, Brutsche MH, von Mering C. 2017. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome. 5:20.
   PubMed Web of Science ®Google Scholar
• Feng YE, Li-Xian HE, Cai BQ, Wen FQ, Chen BY, Hadiarto M, Chen RC. 2013. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chin Med J. 126:2207–2214.
   PubMed Web of Science ®Google Scholar
• Fernaays MM, Lesse AJ, Sethi S, Cai X, Murphy TF. 2006. Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary disease. Infect Immun. 74:3366–3374.
   PubMed Web of Science ®Google Scholar
• Fischer K, Doehn JM, Herr C, Lachner C, Heinrich A, Kershaw O, Voss M, Jacobson MH, Gruber AD, Clauss M, et al. 2018. Acute Moraxella catarrhalis airway infection of chronically smoke-exposed mice increases mechanisms of emphysema development: a pilot study. Eur J Microbiol Immunol (Bp). 8:128–134.
   PubMedGoogle Scholar
• Gallo MC, Kirkham C, Eng S, Bebawee RS, Kong Y, Pettigrew MM, Tettelin H, Murphy TF. 2018. Changes in IgA protease expression are conferred by changes in genomes during persistent Infection by nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease. Infect Immun. 86:e00313.
   PubMed Web of Science ®Google Scholar
• Gao YH, Guan WJ, Liu Q, Wang HQ, Zhu YN, Chen RC, Zhang GJ. 2016. Impact of COPD and emphysema on survival of patients with lung cancer: a meta-analysis of observational studies. Respirology. 21:269–279.
   PubMed Web of Science ®Google Scholar
• George LM, Haigh RD, Mistry V, Haldar K, Barer MR, Oggioni MR, Brightling CE. 2018. Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects. Int J Chron Obstruct Pulmon Dis. 13:3663–3667.
   PubMed Web of Science ®Google Scholar
• [GOLD] Global Initiative for Chronic Obstructive Lung Disease. 2019. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2019 report. https://goldcopd.org/gold-reports/.
   Google Scholar
• Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R. 2017. Eosinophilic and neutrophilic airway inflammation in the phenotyping of mild-to-moderate asthma and chronic obstructive pulmonary disease. COPD. 14:181–189.
   PubMedGoogle Scholar
• Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. 2020. Mechanisms of virus-induced airway immunity dysfunction in the pathogenesis of COPD disease, progression, and exacerbation. Front Immunol. 11:1205.
   PubMed Web of Science ®Google Scholar
• He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J. 2017. Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol. 43:81–95.
   PubMed Web of Science ®Google Scholar
• Heung LJ, Hohl TM. 2019. Inflammatory monocytes are detrimental to the host immune response during acute infection with Cryptococcus neoformans. PLoS Pathog. 15:e1007627.
   PubMed Web of Science ®Google Scholar
• Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, et al. 2010. Disordered microbial communities in asthmatic airways. PLoS One. 5:e8578.
   PubMed Web of Science ®Google Scholar
• Hosgood HD, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J, Vermeulen R, He X, White JR, Wu G, et al. 2014. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen. 55:643–651.
   PubMed Web of Science ®Google Scholar
• Hou HH, Wang HC, Yu CJ. 2018. Mmp-12 activates protease activated receptor (par)-1, upregulates placenta growth factor and leads to pulmonary emphysema. Respirology. 23:47–47.
   Web of Science ®Google Scholar
• Huang YJ, Boushey HA. 2015. The Sputum microbiome in chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc. 12:S176–S180.
   PubMed Web of Science ®Google Scholar
• Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. 2010. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS. 14:9–59.
   PubMed Web of Science ®Google Scholar
• Huerta A, Soler N, Esperatti M, Guerrero M, Menendez R, Gimeno A, Zalacain R, Mir N, Aguado JM, Torres A. 2014. Importance of Aspergillus spp. isolation in acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respir Res. 15:17.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. 2006. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 174:867–874.
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Pandit U, Sethi S. 2019. Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones? Curr Opin Infect Dis. 32:143–151.
   PubMed Web of Science ®Google Scholar
• Jalalvand F, Riesbeck K. 2018. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. Expert Rev Vaccines. 17:503–512.
   PubMed Web of Science ®Google Scholar
• Jin J, Liu X, Sun Y. 2014. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res. 15:130.
   PubMed Web of Science ®Google Scholar
• Johnson MM, Fernandez-Bussy S. 2019. Deciphering the lung microbiome: implications for lung health and disease. Respiration. 97:12–14.
   PubMed Web of Science ®Google Scholar
• Kaufhold I, Osbahr S, Shima K, Marwitz S, Rohmann K, Dromann D, Goldmann T, Dalhoff K, Rupp J. 2017. Nontypeable Haemophilus influenzae (NTHi) directly interfere with the regulation of E-cadherin in lung epithelial cells. Microbes Infect. 19:560–566.
   PubMed Web of Science ®Google Scholar
• Kefala AM, Fortescue R, Alimani GS, Kanavidis P, McDonnell MJ, Magiorkinis E, Megremis S, Paraskevis D, Voyiatzaki C, Mathioudakis GA, et al. 2020. Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol. BMJ Open. 10:e035640.
   PubMed Web of Science ®Google Scholar
• Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, Yang IA. 2016. Acute exacerbation of COPD. Respirology. 21:1152–1165.
   PubMed Web of Science ®Google Scholar
• Kramer CD, Genco CA. 2017. Microbiota, immune subversion, and chronic inflammation. Front Immunol. 8:255.
   PubMed Web of Science ®Google Scholar
• Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, Chung KS, Kim EY, Jung JY, Kang YA, et al. 2016. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 102:89–95.
   PubMed Web of Science ®Google Scholar
• Leung JM, Tiew PY, Mac Aogain M, Budden KF, Yong VF, Thomas SS, Pethe K, Hansbro PM, Chotirmall SH. 2017. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 22:634–650.
   PubMed Web of Science ®Google Scholar
• Lim JU, Yeo CD, Rhee CK, Kim YH, Park CK, Kim JS, Kim JW, Kim SJ, Yoon HK, Lee SH. 2018. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients. Int J Chron Obstruct Pulmon Dis. 13:2139–2146.
   PubMed Web of Science ®Google Scholar
• Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. 2006. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 27:397–412.
   PubMed Web of Science ®Google Scholar
• López Caro JC, Santibáñez M, García Rivero JL, Villanueva M, Sainz J, González González P, Hierro M, Rodríguez Porres M, Paras Bravo P, Mira A, et al.; on behalf of the ACINAR-microbiome study group. 2019. Sputum microbiome dynamics in chronic obstructive pulmonary disease patients during an exacerbation event and post-stabilization. Respiration. 98:447–454.
   PubMed Web of Science ®Google Scholar
• Man WH, de Steenhuijsen Piters WAA, Bogaert D. 2017. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 15:259–270.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, Vestbo J. 2017. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev. 26:160073.
   PubMed Web of Science ®Google Scholar
• Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, et al. 2018. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 0:1–9.
   Google Scholar
• McGuinness AJ, Sapey E. 2017. Oxidative stress in COPD: sources, markers, and potential mechanisms. J Clin Med. 6:21.
   PubMed Web of Science ®Google Scholar
• Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, et al. 2019. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 19:112.
   PubMed Web of Science ®Google Scholar
• Mitchell AB, Oliver BGG, Glanville AR. 2016. Translational aspects of the human respiratory virome. Am J Respir Crit Care Med. 194:1458–1464.
   PubMed Web of Science ®Google Scholar
• Moffatt MF, Cookson WO. 2017. The lung microbiome in health and disease. Clin Med (Lond). 17:525–529.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Grant BJ, Sethi S. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med. 172:195–199.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Pettigrew MM, LaFontaine ER, Tettelin H. 2019. Tettelin H: persistence of Moraxella catarrhalis in chronic obstructive pulmonary disease and regulation of the hag/mid adhesin. J Infect Dis. 219:1448–1455.
   PubMed Web of Science ®Google Scholar
• Negewo NA, Gibson PG, McDonald VM. 2015. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 20:1160–1171.
   PubMed Web of Science ®Google Scholar
• Oever JT, Netea MG. 2014. The bacteriome-mycobiome interaction and antifungal host defense. Eur J Immunol. 44:3182–3191.
   PubMed Web of Science ®Google Scholar
• Oriano M, Terranova L, Teri A, Sottotetti S, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Amati F, Nava F, et al. 2019. Comparison of different conditions for DNA extraction in sputum - a pilot study. Multidiscip Respir Med. 14:6.
   PubMed Web of Science ®Google Scholar
• Pandey KC, De S, Mishra PK. 2017. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol. 8:512.
   PubMed Web of Science ®Google Scholar
• Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, Massion PP, Ocak S, Ware LB, Lee JW, Bowler RP, et al. 2011. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 184:317–327.
   PubMed Web of Science ®Google Scholar
• Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One. 7:e47305.
   PubMed Web of Science ®Google Scholar
• Pragman AA, Knutson KA, Gould TJ, Isaacson RE, Reilly CS, Wendt CH. 2019. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study. Respir Res. 20:114.
   PubMed Web of Science ®Google Scholar
• Pragman AA, Lyu T, Baller JA, Gould TJ, Kelly RF, Reilly CS, Isaacson RE, Wendt CH. 2018. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome. 6:7.
   PubMed Web of Science ®Google Scholar
• Saraya T, Kimura H, Kurai D, Ishii H, Takizawa H. 2017. The molecular epidemiology of respiratory viruses associated with asthma attacks: a single-center observational study in Japan. Medicine (Baltimore). 96:e8204.
   PubMed Web of Science ®Google Scholar
• Saraya T, Kimura H, Kurai D, Tamura M, Ogawa Y, Mikura S, Sada M, Oda M, Watanabe T, Ohkuma K, et al. 2018. Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases. Respir Med. 136:88–92.
   PubMed Web of Science ®Google Scholar
• Schwartz AG, Ruckdeschel JC. 2006. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 173:16–22.
   PubMed Web of Science ®Google Scholar
• Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. 2006. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 173:991–998.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 359:2355–2365.
   PubMed Web of Science ®Google Scholar
• Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF. 2007. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 176:356–361.
   PubMed Web of Science ®Google Scholar
• Shukla SD, Budden KF, Neal R, Hansbro PM. 2017. Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology. 6:e133.
   PubMed Web of Science ®Google Scholar
• Sinha R, Weissenburger-Moser LA, Clarke JL, Smith LM, Heires AJ, Romberger DJ, LeVan TD. 2018. Short term dynamics of the sputum microbiome among COPD patients. PLoS One. 13:e0191499.
   PubMed Web of Science ®Google Scholar
• Skelly AN, Sato Y, Kearney S, Honda K. 2019. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol. 19:305–323.
   PubMed Web of Science ®Google Scholar
• Syamlal G, Doney B, Mazurek JM. 2019. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and Occupation - United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 68:303–307.
   PubMed Web of Science ®Google Scholar
• Sze MA, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, Erb-Downward JR, Huffnagle GB, Hayashi S, Elliott WM, et al. 2015. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 192:438–445.
   PubMed Web of Science ®Google Scholar
• Teo E, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML. 2017. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 6:CD010010.
   PubMedGoogle Scholar
• Thomson NC. 2018. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities. Curr Opin Pharmacol. 40:1–8.
   PubMed Web of Science ®Google Scholar
• Tong X, Cheng A, Xu H, Jin J, Yang Y, Zhu S, Li Y. 2018. Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study. BMC Pulm Med. 18:55.
   PubMed Web of Science ®Google Scholar
• Underhill DM, Iliev ID. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 14:405–416.
   PubMed Web of Science ®Google Scholar
• van Woerden HC, Gregory C, Brown R, Marchesi JR, Hoogendoorn B, Matthews IP. 2013. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis. 13:69.
   PubMed Web of Science ®Google Scholar
• Wang Z, Maschera B, Lea S, Kolsum U, Michalovich D, Horn SV, Traini C, R. Brown J, Hessel EM, Singh D. 2019. Airway host-microbiome interactions in chronic obstructive pulmonary disease. Respir Res. 20:113.
   PubMed Web of Science ®Google Scholar
• Wang Z, Singh R, Miller BE, Tal-Singer R, Horn SV, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, et al. 2017. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax. 0:1–8.
   Google Scholar
• Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, et al. 2018. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 391:1706–1717.
   PubMed Web of Science ®Google Scholar
• White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, Stockley RA. 2003. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax. 58:680–685.
   PubMed Web of Science ®Google Scholar
• Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, Luketich JD, Siegfried JM. 2008. The pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 178:956–961.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. 2017. Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
   Google Scholar
• World Health Organisation. n.d. Burden of COPD. https://www.who.int/respiratory/copd/burden/en/
   Google Scholar
• Xu L, Chen B, Wang F, Wei C, Liu H, Liu J, Herth FJF, Luo F. 2019. A Higher Rate of Pulmonary fungal infection in chronic obstructive pulmonary disease patients with influenza in a large tertiary hospital. Respiration. 98:391–310.
   PubMed Web of Science ®Google Scholar
• Yin T, Zhu Z, Mei Z, Feng J, Zhang W, He Y, Shi J, Qian L, Liu Y, Huang Q, et al. 2018. Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 12:1228–1239.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. 2009. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 34:380–386.
   PubMed Web of Science ®Google Scholar
• Young JC, Chehoud C, Bittinger K, Bailey A, Diamond JM, Cantu E, Haas AR, Abbas A, Frye L, Christie JD, et al. 2015. Viral metagenomics reveal blooms of Anelloviruses in the respiratory tract of lung transplant recipients. Am J Transplant. 15:200–209.
   PubMed Web of Science ®Google Scholar